Table 8.
Thrombotic events (n = 12) | No-thrombotic events (n = 94) | P value | |
---|---|---|---|
INR | 2.16 ± 0.81 | 1.05 ± 0.19 | < 0.001 |
aPPT (s) | 35.76 ± 16.91 | 35.16 ± 13.32 | 0.89 |
Fibrinogen (g/l) | 3.94 ± 1.44 | 3.64 ± 1.49 | 0.52 |
d-Dimer (mg/l) | 15.75 ± 6.67 | 13.67 ± 7.56 | 0.90 |
Factor VIII (%) | 197.35 ± 107 | 144.79 ± 88.82 | 0.07 |
Von Willebrand factor (%) | 310.37 ± 68.37 | 228.41 ± 106.51 | 0.02 |
Protein C (%) | 115.29 ± 68.80 | 111.51 ± 38.44 | 0.78 |
Protein S (%) | 63.79 ± 23.41 | 57.18 ± 30.87 | 0.58 |
Antithrombin III (%) | 100.03 ± 20.66 | 107.62 ± 21.61 | 0.27 |
Lupus anticoagulant-1 (s) | 69.81 ± 15.79 | 62.08 ± 21.39 | 0.25 |
Lupus anticoagulant-2 (s) | 55.46 ± 12.01 | 49.63 ± 13.81 | 0.20 |
LA-1/LA-2 ratio | 1.26 ± 0.08 | 1.23 ± 0.19 | 0.63 |
Data expressed as mean (SD)
s second, INR international randomized ratio, aPPT activated partial thromboplastin time, LA lupus anticoagulant, aPPT activated partial thromboplastin
P value was significant if < 0.05